GPT and fatty liver disease: Regarding treatment response to hepatic steatosis, the univariable analysis revealed that an MVPA ≥ 150 min/week, baseline LFC, reduction in FBG (ΔFBG), and reduction in ALT (ΔALT, per 10 IU/L decrease) were associated with MRI-PDFF non-response.